Caue Zortea is the founder of PhageLab. PhageLab has raised $40M in total funding. Latest round: Seed. Backed by Kaszek Ventures, Nazca, Collaborative Fund.
Caue Zortea is the Chief Executive Officer of PhageLab, a Chilean biotechnology company that develops bacteriophage-based solutions to combat antibacterial resistance in animal health. A former Eli Lilly executive, he assumed the CEO role in February 2026.
Full founder directory · Investor directory · Company funding database · Fundraising library